FDA Refuses to Review Moderna’s mRNA Influenza Shot License Application
The U.S. Food and Drug Administration (FDA) has declined to accept for review Moderna’s Biologics License Application (BLA) for its mRNA-based seasonal influenza shot, citing concerns about the completeness of the submission. The decision highlights the agency’s commitment to maintaining clear evidentiary standards for approving the licensing of new vaccines.1 On Feb. 3, 2026, the […]
Changes in Eye Health Linked to mRNA COVID-19 Shots
A recent prospective study published in 2025 in Ophthalmic Epidemiology has identified measurable changes in the cornea of the eye following receipt of mRNA COVID-19 biological, raising new questions about potential effects on eye health. Researchers observed differences in corneal thickness and endothelial cell characteristics in healthy adults after two doses of Pfizer/BioNTech’s Comirnaty COVID […]
Nursing Home Residents Routinely Given Vaccines Rarely Represented in Clinical Trials
According to researchers at the University of Aberdeen in Scotland, people living in older care homes have been largely excluded from vaccine trials, despite being among the groups most likely to receive vaccines, especially during public health emergencies. Researchers say this mismatch has limited the evidence available on how vaccines perform in care nursing home […]
CDC Changes Recommendations for Six Childhood Vaccines
The U.S. Department of Health and Human Services (DHHS) announced updates to the national childhood vaccine schedule involving six vaccines (rotavirus, COVID-19, influenza, meningococcal disease, hepatitis A, and hepatitis B) following a presidential memorandum directing the U.S. Centers for Disease Control and Prevention (CDC) to review and revise its recommendations. The changes clarify which vaccines […]
Moderna Secures CEPI Funding for mRNA Bird Flu Vaccine After U.S. Cancels Funding
Moderna secured new funding from an international organization for its experimental mRNA bird flu vaccine after the U.S. Department of Health and Human Services (DHHS) pulled back approximately $700 million in previously committed funding last year. The biotechnology company said that it will receive up to $54.3 million from the Coalition for Epidemic Preparedness Innovations […]
CDC Changes Hepatitis B Vaccine Birth Dose Recommendation for Newborns
The U.S. Centers for Disease Control and Prevention (CDC) has stopped recommending that all newborns receive the hepatitis B vaccine at birth, marking a significant shift in a policy that has been in place for decades. The change followed a vote by members at a Dec. 5, 2025 meeting of the Advisory Committee on Immunization […]